17.64

1.89% -0.34

After Hours: 18.00 0.36 +2.04%

Corbus Pharmaceuticals Holdings Inc (CRBP)

Overview News Price History Financials Discussions Forecast Stock Split

Corbus Pharmaceuticals Holdings Inc stock is traded at $17.64, with a volume of 154.83K. It is down -1.89% in the last 24 hours and up +8.15% over the past month. Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Previous Close:

$17.98

Open:

$17.93

24h Volume:

154.83K

Relative Volume:

0.24

Market Cap:

$216.67M

Revenue:

$1.54M

Net Income/Loss:

$-38.70M

P/E Ratio:

-1.6036

EPS:

-11

Net Cash Flow:

$-36.86M

1W Performance:

+9.70%

1M Performance:

+8.15%

6M Performance:

-60.82%

1Y Performance:

+319.00%

1-Day Range:

$17.54

$18.15

1-Week Range:

$16.08

$18.43

52-Week Range:

$4.06

$61.90

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile

Name

Corbus Pharmaceuticals Holdings Inc

Sector

Healthcare (1200)

Industry

Biotechnology (682)

Phone

617-963-0103

Address

500 RIVER RIDGE DRIVE, NORWOOD, MA

Employee

Twitter

@corbuspharma

Next Earnings Date

2024-11-05

Latest SEC Filings

CRBP's Discussions on Twitter

Compare CRBP with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CRBP Corbus Pharmaceuticals Holdings Inc	17.64	216.67M	1.54M	-38.70M	-36.86M	-11.00
VRTX Vertex Pharmaceuticals Inc	464.56	119.70B	10.63B	-479.80M	-1.35B	13.33
REGN Regeneron Pharmaceuticals Inc	754.87	82.75B	13.85B	4.65B	3.32B	35.06
ARGX Argen X Se Adr	614.59	36.73B	1.86B	-40.29M	-1.28B	-4.16
ALNY Alnylam Pharmaceuticals Inc	253.74	32.53B	2.09B	-332.26M	16.06M	-4.14
BNTX Biontech Se Adr	120.72	28.50B	3.30B	-501.07M	1.03B	11.54

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-30-24	Initiated	Wedbush	Outperform
Jul-22-24	Resumed	H.C. Wainwright	Buy
Jun-26-24	Initiated	B. Riley Securities	Buy
Jun-03-24	Reiterated	Oppenheimer	Outperform
May-13-24	Initiated	RBC Capital Mkts	Outperform
Mar-06-24	Upgrade	Jefferies	Hold → Buy
Sep-08-20	Downgrade	BTIG Research	Buy → Neutral
Sep-08-20	Downgrade	Jefferies	Buy → Hold
Sep-08-20	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Sep-08-20	Downgrade	ROTH Capital	Buy → Neutral
Jul-07-20	Initiated	ROTH Capital	Buy
Jun-17-20	Initiated	BTIG Research	Buy
Mar-26-20	Initiated	Nomura	Buy
Apr-05-19	Initiated	Jefferies	Buy
Mar-20-19	Initiated	Oppenheimer	Outperform
Jan-11-19	Reiterated	Cantor Fitzgerald	Overweight
Dec-26-18	Initiated	H.C. Wainwright	Buy
Dec-07-18	Initiated	RBC Capital Mkts	Outperform
Oct-24-18	Initiated	B. Riley FBR	Buy
Jan-19-18	Initiated	Raymond James	Outperform
Dec-14-17	Reiterated	Cantor Fitzgerald	Overweight
Nov-08-17	Reiterated	Noble Financial	Buy
Sep-29-17	Resumed	Noble Financial	Buy
Mar-30-17	Reiterated	Cantor Fitzgerald	Overweight
Nov-15-16	Reiterated	JMP Securities	Mkt Outperform
Nov-11-16	Reiterated	Noble Financial	Buy

View All

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Latest News

Nov 26, 2024

Corbus Pharmaceuticals Holdings Inc. stock rises Tuesday, still underperforms market - MarketWatch

Nov 26, 2024